Menu Search
Equities

Synektik SA

SNT:WSE

Synektik SA

Actions
Health CareHealth Care Providers
  • Price (PLN)181.00
  • Today's Change3.00 / 1.69%
  • Shares traded12.07k
  • 1 Year change+167.75%
  • Beta--
Data delayed at least 15 minutes, as of Nov 08 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in PLNIncome statement in PLNView more

Year on year Synektik SA grew revenues 167.81% from 166.86m to 446.87m while net income improved 409.18% from 10.30m to 52.45m.
Gross margin26.65%
Net profit margin12.85%
Operating margin17.08%
Return on assets26.04%
Return on equity54.95%
Return on investment41.65%
More ▼

Cash flow in PLNView more

In 2023, Synektik SA increased its cash reserves by 547.44%, or 52.98m. The company earned 96.13m from its operations for a Cash Flow Margin of 21.51%. In addition the company used 11.55m on investing activities and also paid 31.60m in financing cash flows.
Cash flow per share10.40
Price/Cash flow per share17.41
Book value per share20.09
Tangible book value per share14.89
More ▼

Balance sheet in PLNView more

Synektik SA has a Debt to Total Capital ratio of 9.09%, a lower figure than the previous year's 11.39%.
Current ratio1.48
Quick ratio1.28
Total debt/total equity0.0999
Total debt/total capital0.0909
More ▼

Growth rates in PLN

Year on year, both dividends per share and earnings per share excluding extraordinary items growth increased 405.00% and 409.18%, respectively. The positive trend in dividend payments is noteworthy since very few companies in the Medical Equipment & Supplies industry pay a dividend.
Div yield(5 year avg)3.16%
Div growth rate (5 year)--
Payout ratio (TTM)0.00%
EPS growth(5 years)--
EPS (TTM) vs
TTM 1 year ago		104.40
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.